Copeptin: Limited Usefulness in Early Stroke Differentiation?
Background. Stroke can be a challenging diagnosis in an emergency-setting. We sought to determine whether copeptin may be a useful biomarker to differentiate between ischemic stroke (IS), transient ischemic attack (TIA), and stroke-mimics. Methods. In patients with suspected stroke arriving within 4...
Saved in:
| Main Authors: | Johannes von Recum, Julia Searle, Anna Slagman, Jörn Ole Vollert, Matthias Endres, Martin Möckel, Martin Ebinger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Stroke Research and Treatment |
| Online Access: | http://dx.doi.org/10.1155/2015/768401 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medical History of Elderly Patients in the Emergency Setting: Not an Easy Point-of-Care Diagnostic Marker
by: Tobias Lindner, et al.
Published: (2015-01-01) -
Copeptin as biomarker for acute ischemic stroke prognosis and revascularization treatment efficacy
by: Antonia Ioana Vasile, et al.
Published: (2024-12-01) -
SIGNIFICANCE OF COPEPTIN IN DIAGNOSTICS OF MYOCARDIAL INFARCTION
by: L. V. Kremneva
Published: (2017-12-01) -
High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS
by: Diana Hernández-Romero, et al.
Published: (2012-01-01) -
Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
by: I. Wojsyk-Banaszak, et al.
Published: (2019-01-01)